Evidence map›Paper›PMID 29696074›Full record

ArticleJournal of extracellular vesicles2018

Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.

Jordi Berenguer, Tonny Lagerweij, Xi Wen Zhao, Sophie Dusoswa, Petra van der Stoop, Bart Westerman, Mark C de Gooijer, Marloes Zoetemelk, Anoek Zomer, Matheus H W Crommentuijn and 19 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Loading of therapeutic cell penetrating peptides into extracellular vesicles for pulmonary fibrosis.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  7. Extracellular vesicles in viral disease management.Current research in microbial sciences · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. G protein-coupled receptors: a gateway to targeting oncogenic EVs?Extracellular vesicles and circulating nucleic acids · 2024
    Review
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 6 institutions in 3 countries.

Jordi BerenguerDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Tonny LagerweijDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0003-1043-7452
Xi Wen ZhaoDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Sophie DusoswaDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
Petra van der StoopDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Bart WestermanDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-9898-9616
Mark C de GooijerDepartment of Bio-Pharmacy/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0002-2812-991X
Marloes ZoetemelkDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Anoek ZomerCancer Genomics Netherlands, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-7209-6476
Matheus H W CrommentuijnDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-8217-5370
Laurine E WedekindDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Àlan López-LópezDepartment of Physiological Sciences I, University of Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Barcelona, Spain.
Alberta GiovanazziDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Marina Bruch-OmsDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
Ida H van der Meulen-MuilemanDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-3821-9927
Rogier M ReijmersDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-7471-7715
Toin H van KuppeveltDepartment of Matrix Biochemistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Juan-Jesús García-VallejoDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-6238-7069
Yvette van KooykDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-5997-3665
Bakhos A TannousDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Pieter WesselingDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-5453-5201
Danijela Koppers-LalicDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
W Peter VandertopDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
David P NoskeDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Victor W van BeusechemDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Jacco van RheenenCancer Genomics Netherlands, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, The Netherlands.
D Michiel PegtelDepartment of Matrix Biochemistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Olaf van TellingenDepartment of Bio-Pharmacy/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Thomas WurdingerDepartment of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLHarvard University · USUniversity Medical Center Utrecht · NLRadboud University Nijmegen · NLThe Netherlands Cancer Institute · NLCentro de Investigación Biomédica en Red · ES

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHIOCCA, E. ANTONIO · 1996 to 2021
$30.9M
NCI NIH HHS P01 CA069246
6 · The paper itself

Abstract

Cancer cells release extracellular vesicles (EVs) that contain functional biomolecules such as RNA and proteins. EVs are transferred to recipient cancer cells and can promote tumour progression and therapy resistance. Through RNAi screening, we identified a novel EV uptake mechanism involving a triple interaction between the chemokine receptor CCR8 on the cells, glycans exposed on EVs and the soluble ligand CCL18. This ligand acts as bridging molecule, connecting EVs to cancer cells. We show that glioblastoma EVs promote cell proliferation and resistance to the alkylating agent temozolomide (TMZ). Using

Indexed as

CCR8Chemokine receptorExtracellular vesiclesglioblastomaglycansRNAi screeningtemozolomidetherapy resistance

Identifiers

PMID29696074
PMCPMC5912193
OpenAlexW2792418106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.